DI
AGIO icon

Disciplined Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Disciplined Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$57 – 145
2023
Q2 		$57 Hold
2
– – ﹤0.01% 1649
2023
Q1 		$46 Sell
2
-1
-33% -$27 ﹤0.01% 1637
2022
Q4 		$84 Buy
3
+1
+50% +$28 ﹤0.01% 1546
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1198
2022
Q2 		$0 Hold
2
– – ﹤0.01% 1230
2022
Q1 		$0 Buy
+2
New +$61 ﹤0.01% 1312

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Disciplined Investments's AGIO Position: Q3 2023 in Review

Disciplined Investments sold out of Agios Pharmaceuticals (AGIO) in Q3 2023, closing a stake of 2 shares — an estimated $57 sold.

Disciplined Investments first reported a position in AGIO in Q1 2022 and held it in 6 quarters. The position peaked at $84 in Q4 2022. 144 funds tracked by Wall St. Rank hold AGIO as of Q3 2023.

  • Disciplined Investments reported no remaining Agios Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 2 Agios Pharmaceuticals shares in Q3 2023, an estimated $57.
  • Disciplined Investments first reported a position in Agios Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Agios Pharmaceuticals position peaked at $84 in Q4 2022.
  • 144 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.